Top 10 Tech Stocks To Watch For 2015

Radnor, Pa.-based Qlik Technologies (NASDAQ: QLIK  ) has purchased Sweden's NComVA AB, Qlik announced Monday.

NComVA tech permits the display of business intelligence data "through table lens, radar plot, scatter matrix, parallel coordinate, tree map, and fish eye bars," and also "allows users to see how changes in data relate to each other and the passing of time."

A Qlik partner company since 2011, NComVA specializes in "advanced visualization technology," which Qlik says will help in "delivering a deeper understanding of data" by making relationships easier to see, "especially when multiple data sources are analyzed together."

Qlik did not disclose financial specifics of the acquisition, revealing neither the price it's paying, nor the revenue streams or profits numbers of the company it's getting. Nonetheless, investors applauded the deal, bidding up Qlik shares by 2.2% to close at $26.81 in Monday trading.

Top 10 Tech Stocks To Watch For 2015: KongZhong Corporation(KONG)

KongZhong Corporation, together with its subsidiaries, provides wireless interactive entertainment, media, and community services to mobile phone users in the People's Republic of China. It also involves in the development, distribution, and marketing of consumer wireless value-added services, including wireless application protocol, multimedia messaging services, short messaging services, interactive voice response services, and color ring back tones. In addition, it offers interactive entertainment services, such as mobile games, pictures, karaoke, electronic books, mobile phone personalization features, entertainment news, chat, and message boards; and through Kong.net offer news, community services, games, and other interactive media and entertainment services; and sells advertising space in the form of text-link, banner, and button advertisements. Further, the company develops and publishes mobile games, including downloadable mobile games and online mobile games cons isting of action, role-playing, and leisure games. As of December 31, 2009, it had a library of approximately 300 internally developed mobile games. Additionally, it develops online games; and provides consulting and technology services, as well as media and net book services. The company was formerly known as Communication Over The Air Inc. and changed its name to KongZhong Corporation in March 2004. KongZhong Corporation was founded in 2002 and is headquartered in Beijing, the People?s Republic of China

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Kongzhong (Nasdaq: KONG  ) , whose recent revenue and earnings are plotted below.

• [By Roberto Pedone]

  One under-$10 wireless services player that looks poised for a big spike higher is KongZhong (KONG), which is a provider of WVAS and mobile games to mobile phone users and a wireless media company providing news, content, community and mobile advertising services through its wireless Internet sites in the PRC. This stock is off to a hot start in 2013, with shares up sharply by 53%.

  If you take a look at the chart for KongZhong, you'll notice that this stock has been downtrending badly for the last two months, with shares plunging lower from its high of $14.92 to its recent low of $7.78 a share. During that downtrend, shares of KONG have been consistently making lower highs and lower lows, which is bearish technical price action. That move has now pushed shares of KONG into oversold territory, since its current relative strength index reading is 30.21. Shares of KONG are now starting to spike higher off its recent low of $7.78 a share and off its 200-day moving average of $7.95 a share. This spike could be signaling that the downside volatility for KONG is over in the short-term and the stock is ready to trend higher.

  Traders should now look for long-biased trades in KONG if it manages to break out above some near-term overhead resistance at $8.50 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 519,857 shares. If that breakout triggers soon, then KONG will set up to re-test or possibly take out its next major overhead resistance levels at $10 to its 50-day moving average at $11.33 a share.

  Traders can look to buy KONG off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $7.78 a share. One can also buy KONG off strength once it takes out $8.50 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By Jake L'Ecuyer]

  Top losers in the sector included China Unicom (Hong Kong) (NYSE: CHU), off 4.5 percent, and Kongzhong (NASDAQ: KONG), down 4.7 percent.

  Top Headline
  The Boeing Company (NYSE: BA) reported better-than-expected first-quarter profit. Boeing's quarterly profit declined to $965 million, or $1.28 per share, from a year-ago profit of $1.11 billion, or $1.44 per share. Its adjusted earnings surged to $1.76 per share compared to $1.73 per share. Its revenue climbed to $20.47 billion versus $18.89 billion. However, analysts were projecting earnings of $1.57 per share on revenue of $20.24 billion. For the full year, Boeing expects adjusted earnings of $7.15 to $7.35 per share.

Top 10 Tech Stocks To Watch For 2015: Redhill Biopharma Ltd (RDHL)

Redhill Biopharma Ltd. is an Israel-based biopharmaceutical company. The Company is focused on the development and acquisition of therapeutic candidates. The Company�� pipeline consists of six late clinical development therapeutic candidates, two of which have completed bioequivalence clinical trials subject to review and approval by the United States Food and Drug Administration and, in some cases, regulatory authorities in other countries. The Company�� six clinical stage therapeutic candidates include RHB-101, RHB-102, RHB-103, RHB-104, RHB-105 and RHB-106.

RHB-101

RHB-101 is a treatment of hypertension, heart failure and left ventricular dysfunction (following myocardial infraction) by means of controlled release of an active ingredient known as carvedilol, which is designed to be administered to patients on a once-daily basis. RHB-101 is based on a patented technology for the controlled release of drugs administered orally.

RHB-102

RHB-102 is a once-daily controlled release oral formulation of ondansetron. RHB-102 utilizes a technology called CDT that uses salts to provide a controlled release of ondansetron.

RHB-103

RHB-103 is an oral thin film formulation of rizatriptan intended for the treatment of acute migraine headaches. Migraine is a neurovascular disorder (related to nerves and blood vessels) characterized by recurrent headaches in one side or both sides of the head.

The product is based on a technology called VersaFilm.

RHB-104

RHB-104 is an antibiotic combination therapy for the treatment of Crohn's disease (with a PIII clinical study underway), as well as Multiple Sclerosis (with an ongoing PIIa clinical study) and Rheumatoid Arthritis. RHB-104 is a combination of clarithromycin, clofazimine and rifabutin, three generic antibiotic ingredients, in a single capsule.

RHB-105

RHB-105, an antibiotics and proton pump inhibitor drug targeting Helico! bacter Pylori infection. RHB-105 is a combination of three approved drug products omeprazole, which is a proton pump inhibitor (the natural body pump that produces the gastric acids used for digesting the food in the stomach), and amoxicillin and rifabutin which are antibiotics. Chronic infection with Helicobacter pylori irritates the mucosal lining of the stomach and small intestine.

RHB-106

RHB-106, is a tablet for the preparation and cleansing of the gastrointestinal tract prior to the performance of abdominal procedures. Its abdominal procedures include diagnostic tests, such as colonoscopy, barium enema or virtual colonoscopy, as well as surgical interventions, such as laparotomy.

The company competes with GlaxoSmithKline, Sanofi-Aventis Groupe, Hoffman-La Roche Ltd, Merck and Co., Inc, Ferring Pharmaceuticals and Salix Pharmaceuticals Inc.

Advisors' Opinion:

• [By Monica Gerson]

  Breaking news

  Vitran Corporation (NASDAQ: VTNC) announced today that it has entered into a definitive arrangement agreement with TransForce pursuant to which TransForce has agreed to acquire all of the outstanding common shares of Vitran not already owned by TransForce for US$6.50 in cash per share, in accordance with TransForce's prior proposal. To read the full news, click here. ReneSola (NYSE: SOL) today announced it signed a Memorandum of Intent (MOI) to sell three utility-scale projects in Western China, with a total capacity of 60MW, to Jiangsu Akcome Solar Science & Technology Co on December 30, 2013. To read the full news, click here. Cooper Tire & Rubber Company (NYSE: CTB) today announced it has terminated the merger agreement with Apollo Tyres (NSE:ApolloTYRE). To read the full news, click here. RedHill Biopharma (NASDAQ: RDHL) today announced that it has entered into a definitive agreement with leading healthcare investor OrbiMed Israel Partners Limited Partnership, an affiliate of OrbiMed Advisors LLC, for the sale of RedHill's American Depository Shares and warrants in a private placement transactionor a total sum of $6.0 million. To read the full news, click here.

  Posted-In: Guggenheim US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

Top 10 Retail Stocks To Buy Right Now: Sohu.Com Inc (SOHU)

Sohu.com Inc. (Sohu), incorporated in August 1996, is a Chinese online media, search, gaming, community and mobile service group. The Company operates matrices of Chinese language Web properties, and it operates multi-player online games and Web-based games in the People�� Republic of China. Its businesses consist of the online advertising business, the online game business, the wireless business and the others business, among which online advertising and online games are its core businesses. Its online advertising business consists of the brand advertising business, as well as the search and others business. Its brand advertising business offers products and services, such as free of charge premier content, interactive community and other competitive Internet services to its users, and provides advertising services to advertisers on its matrices of Chinese language Web properties consisting of sohu.com, a portal and online media destination; focus.cn, a real estate Website; and 17173.com, a game information portal. On December 15, 2011, the Company sold assets associated with the business of 17173.com (the 17173 Business), a game information portal in China to Changyou.com Limited (Changyou). On August 1, 2011, The Company acquired Focus Yiju Network Information Technology Co., Ltd. (Focus Yiju). On May 11, 2011, Changyou acquired, through its VIE Gamease, 68.258% of the interests of 7Road Technology Co., Ltd. (7Road).

The Company�� brand advertising business offers advertisements on its Web properties to companies. Its search and others business, provided by its search subsidiary Sogou Inc. (Sogou), offers customers pay-for-click services, priority placements in a search directory, and online marketing services on the Sogou Web Directory. Its online game business is conducted through Sohu�� subsidiary Changyou, which is an online game developer and operator in China. Changyou engages in the development, operation and licensing of online games, including massively multi-player onl! ine games (MMOGs) and Web-based games. Changyou developed and operates MMOGs Tian Long Ba Bu (TLBB) and, through licensees, operates DDTank, which is a multi-player Web-based shooting games in China.

The Company�� wireless business offers mobile related services through different types of wireless products to mobile phone users. The mobile related services consist of the provision of content, such as news, weather forecasts, chatting, entertainment information, mobile games, mobile phone ringtones and logo downloads. The content is purchased from third party content providers. The wireless products consist of short messaging services (SMS), Ring Back Tone (RBT), interactive voice response (IVR) and mobile games. Its others business includes sub-licensing of licensed video content to third parties and offering cinema advertisement slots to be shown in theaters before the screening of movies.

Online Advertising Business

The Company�� brand advertising business falls into fits categories: online portal, online video, vertical sites, and community and communication products. Sohu portal consists of Chinese language Web navigational capabilities, a range of main content channels, and Web-based communication and community services. It offers a range of free channels, which provides comprehensive content. Sohu Video is an online video service provider in China. It delivers licensed professionally produced video content and original in-house produced video content. It provides users free access its video content library, such as domestic and overseas television dramas, movies, television programs, documentaries, news, animations, entertainment related contents, live television Webcasts, in-house produced shows and programs, and user-generated content. It also offers selected content, such as movies and educational content on its advertisement-free paid channel.

Focus.cn is a real estate Websites in China, providing solutions for house seekers, homeowners! , potenti! al property or household appliance buyers with high incomes, and real estate professionals. Focus.cn provides new home and existing home information and develops thousands of homeowner�� online forums in over 100 cities across China, such as Beijing, Shanghai, Tianjin, Guangzhou and Shenzhen. The 17173.com Website provides news channels, which cover topics of interest to game players, including news channels for MMOGs, Web-based games and Flash games, community pages for game player unions, and game pages for different online games.

Communication and community services help users to build customized space and personalized page layouts and offer information sharing and real-time communication. It offers a range of communication and community tools for its Chinese online users, which is promoting user affinity to its portal network micro-blog, message boards, blog and e-mail.

Micro-blog enables the Company�� users to follow topics being discussed online, as well as discussions related to people they know. Message Boards allow users to post and exchange information on message boards covering 50 topics, including education, travel, fashion, sports and all-news Web pages. Blog is an interactive platform for users to build their personalized space by posting their articles and pictures, uploading videos, and sharing information among users. In addition, Sohu blogs provide multiple applications for user-customized front page layouts, interactive communication facilities and services integrated with a selection of Sohu products. E-Mail offers free e-mail services with up to two gigabytes of memory and mail services with different features.

The Company provides brand advertising services across its matrices of Web properties. Its offerings enable advertisers to post their advertisements in different forms, including textual, rich media and video advertisements, and in different locations across the Sohu matrix of Web properties. Its brand advertising products include b! anners, l! inks, logos, buttons and stream advertisements placed on its Websites and sponsorships, which focus on a particular event or a particular Website area. It charges advertisers on a time basis with fixed fees. It also adopted a Cost Per Click (CPC) pricing model and a Cost Per Impression (CPM) pricing model. During the year ended December 31, 2011, approximately 2,600 companies advertised on its Websites. Its customers include multinational companies, which have operations in Chinese markets, as well as Chinese domestic companies.

Sogou.com, which means Search Dog, is Sohu�� search engine. Upon a search query, the user is taken through an interactive process to reach integrated Website and page search results. Sogou Browser is its self-developed browser. Sogou browser has features, including embedded playing of Web video, quick proxy functions for education networks, smart address bar, privacy protection mode, and a column for the most-visited Websites. During 2011, it launched a new version of Sogou browser, which accelerates browsing speeds and adds Web page update notification feature, as well as an online shopping security protection function. Sogou Web Directory is a Chinese Web directory navigation site which serves as an access point to Websites and applications. Online marketing services on Sogou Web Directory consist of displaying links to Sogou�� advertisers��Websites on the Web pages of Sogou Web Directory. Sogou Pinyin is the Company�� self-developed Chinese character input method software, with a vocabulary database that is tied to the search queries database of the Sogou search engine and can capture the latest trends in words used by Internet users.

Online Game Business

The Company�� online game business is conducted through Changyou. Changyou is an online game developer and operator in China by its games TLBB and DDTank. Changyou engages in the development, operation and licensing of MMOGs, which are interactive online games, which may be ! played si! multaneously by game players, and Web-based games, which are played over the Internet using a Web browser. Changyou operates several MMOGs in China, including the in-house developed TLBB and Duke of Mount Deer (DMD) and other MMOGs, which Changyou has licensed from third parties. As of December 31, 2011, Changyou�� MMOGs in China had approximately 175.5 million aggregate registered accounts. Changyou also licenses DDTank, a Web-based game developed by Changyou�� variable interest entity (VIE) 7Road. TLBB is licensed to third-party operators in Vietnam, Taiwan, Hong Kong, Malaysia and Thailand. DDTank is licensed to third-party operators in China, Vietnam, Malaysia, Taiwan, and Brazil. Changyou also operates a modified version of TLBB in the United States and certain European countries. All of Changyou�� games are operated under the item-based revenue model, where game players play the games for free but can purchase virtual items.

TLBB is an in-house developed 2.5D martial arts MMORPG adapted from Chinese novel, Tian Long Ba Bu. TLBB features a combination of martial arts-style-fighting and community-building among its game players. As of December 31, 2011, Changyou has developed 21 expansion packs. DDTank is a two dimensional (2D) Q-style Web-based shooting game developed by Changyou�� VIE 7Road. Players use keyboards to control weapons to compete with others, using different weapons to produces different firing effects. The game features a master and apprentice system, a card system, and customization options for avatars. DMD is an in-house developed three dimensional (3D) martial arts MMORPG. The game recreates Louis Cha�� final martial arts world with cartoon-style graphics, supported by 3D animation engine. The Blade Online (BO) series consist of two 2.5D martial-arts style fighting MMORPGs, BO, which Changyou licensed from a third party, and BH2, which is a sequel of BO. Both games are martial arts-style fighting games set to the backdrop of a Chinese myth. In BO, game play! ers can s! et their own rules for in-game fighting and take on various roles, including a human, an evil spirit or an immortal in the game. Each role has different skill sets that can be learned and improved by completing different tasks. BH2 incorporates features of BO, as well as features, such as maps, characters, fighting techniques and additional team-combat functions to give players a more intense and realistic fighting experience. DHSH is a 2D Q-style, turn-based MMORPG, which Changyou licensed from a third party.

SJQY is a 2D cartoon-style turn-based MMORPG, which Changyou licensed from a third party. Adapted from the novels, Journey to the West, it engages game players in martial arts combat and other activities, such as gardening and home building.

Changyou has several MMOGs and Web-based games in its pipeline with different graphic styles, themes and features. Games in Changyou�� pipeline include the MMORPG Tao Yuan and the Web-based game Shen Qu, which Changyou is developing in-house, and the massively multi-player first-person shooter game (MMOFPS) (MMOFPS is a subset of the MMOG category) Battlefield Online, which Changyou licensed from a third party.

Tao Yuan is a 3D cartoon-style turn-based MMORPG adapted from the stories of Three Kingdoms heroes. The game is created using the Unreal3 game engine and features cartoon-style characters and 3D graphics. The game incorporates traditional Chinese culture, such as five elements, divination inquiry and Chinese acupuncture treatment, into its gameplay design. Battlefield Online is a MMOFP developed from Electronic Arts Inc.�� Battlefield franchise, a series of first-person shooter games, for the personal computer (PC). Battlefield Online is focused on the fights for interests between the Empire and the Commonwealth. The game allows players not only to compete in small teams in group battles and raids, but also to participate in large-scale combat of up to 100 players. In addition, sub-categories of battle classes! can be f! ound in Battlefield Online. Shen Qu is a 2.5D real time strategy Web-based game set against a western universe, which is being developed by Changyou�� VIE 7Road. The game focuses on the exploration of cities and instances. When exploring instances, players can experience diverse playing modes, including chasing, escaping and counterattacking, and finally become the overlord of an area.

Wireless Business and Other Business

The Company�� wireless business offers mobile related services through different types of wireless products to mobile phone users. The mobile related services consist of the provision of content, such as news, weather forecasts, chatting, entertainment information, mobile games, mobile phone ringtones and logo downloads. The content is purchased from third party content providers. The wireless products consist of SMS, RBT, IVR and mobile games. Its other businesses includes sub-licensing of licensed video content to third parties and offering cinema advertisement slots to be shown in theaters before the screening of movies.

The Company competes with Sina Corporation, Tencent Holdings Ltd., NetEase.com, Inc., YouKu Inc., Tudou Holdings Limited, Beijing Xin Lian Xin De Advertising Media Co., Ltd., SouFun Holdings Limited, China Real Estate Information Corporation, Bitauto Holdings Limited, Bitauto Holdings Limited, Guangzhou Hua Duo Network Technology Co., Ltd., Pacific Online Limited, Yahoo! Inc., Microsoft Corporation, AOL Inc., Qihoo 360 Technology Co., Ltd., Baidu, Shanghai Ruichuang Internet Technology Development Co., Ltd., Google, Qihoo, Maxthon International Limited, Mozilla Corporation, Shanda Games Limited, Perfect World Co., Ltd., Giant Interactive Group Inc., NetDragon Websoft Inc., Kingsoft Corporation Limited, The9 Limited, Shenzhen ZQGame Co., Limited, Taomee Holdings Limited, Beijing Guangyu Huaxia Technology Limited, Guang Huan Zhong, Hangzhou Bianfeng Technology Limited, Shanghai Game Reign Network Technology Limited, Play Town! Entertai! nment Limited, Tian Shen Hu Dong Limited, Sichuan Tianshang Youjia Technology Limited and Suzhou Snail Electronics Limited.

Advisors' Opinion:

• [By Paul Ausick]

  Add to that a rumored attempt to acquire Sohu.com Inc. (NASDAQ: SOHU), a Baidu competitor, that currently gets about a quarter of China�� search market. The deal fell through, but in today�� earnings report the company said that it plans to continue to invest in ��roduct and technology development ��particularly in mobile Internet and search technology where we see tremendous opportunity for future expansion.��/p>

• [By Rick Munarriz]

  Reports late last week claim that the new Chinese dot-com darling is in talks to acquire Sohu.com's (NASDAQ: SOHU  ) Sogou search engine.

Top 10 Tech Stocks To Watch For 2015: Inovio Pharmaceuticals Inc (INO)

Inovio Pharmaceuticals, Inc., incorporated on June 29, 1983, is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV). The Company's electroporation delivery technology uses brief, controlled electrical pulses to increase cellular uptake of the vaccine. Its clinical programs include cervical dysplasia (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), hepatitis C virus (HCV) and HIV vaccines. It is advancing preclinical research and clinical development for a universal seasonal/pandemic influenza vaccine, as well as preclinical work for other products, including malaria and prostate cancer vaccines. Its partners and collaborators include University of Pennsylvania, Drexel University, National Microbiology Laboratory of the Public Health Agency of Canada, Program for Appropriate Technology in Health/Malaria Vaccine Initiative (PATH/MVI), National Institute of Allergy and Infectious Diseases (NIAID), Merck, ChronTech, University of Southampton, United States Military HIV Research Program (USMHRP), the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and HIV Vaccines Trial Network (HVTN). As of December 31, 2011 it owned 16.1% interest in VGX Int��.

Inovio�� Solution

The Company�� synthetic vaccine platform consists of its SynCon vaccine design process and electroporation delivery technology. It has developed a preclinical and clinical stage pipeline of vaccines. The Company�� synthetic vaccines are designed to prevent a disease (prophylactic vaccines) or treat an existing disease (therapeutic vaccines). Its synthetic vaccine consists of a deoxyribonucleic acid (DNA) plasmid encoding a selected antigen! (s), which is introduced into cells of humans or animals with the purpose of evoking an immune response to the encoded antigen. The Company�� synthetic vaccines are designed to generate specific antibody and/or T-cell responses.

The Company�� SynCon technology provides processes that employ bioinformatics, which combine extensive genetic data and sophisticated algorithms. Its design process uses the genetic make-up of a common antigen(s) from multiple strains of a virus within a viral sub-type or taxonomic group (family) of pathogens, such as HIV, hepatitis C virus (HCV), human papillomavirus (HPV), influenza and other diseases to synthetically create a new antigen for the desired pathogen target that does not exist in nature. Its synthetic vaccine candidates are being delivered into cells of the body using its electroporation (EP) DNA delivery technology.

Cancer Synthetic Vaccines

The Company has two broad types of cancer vaccines: preventive (or prophylactic) vaccines, which are intended to prevent cancer from developing in healthy people, and treatment (or therapeutic) vaccines, which are intended to treat an existing cancer by strengthening the body�� natural defenses against the cancer. Two types of cancer preventive vaccines are available in the United States. The United States Food and Drug Administration (the FDA) has approved two vaccines, Gardasil and Cervarix that protect against infection by the two types of HPV-types 16 and 18-that cause approximately 70% of all cases of cervical cancer worldwide. In addition, Gardasil protects against infection by two additional HPV types, 6 and 11, which are responsible for about 90% of all cases of genital warts in males and females but do not cause cervical cancer.

Cervarix manufactured by GlaxoSmithKline, is composed of virus-like particles (VLPs) made with proteins from HPV types 16 and 18. Cervarix is approved for use in females��ages 10 to 25 for the prevention of cervical cancer caused by! HPV type! s 16 and 18. Gardasil manufactured by Merck, is approved for use in females for the prevention of cervical cancer, and some vulvar and vaginal cancers, caused by HPV types 16 and 18 and for use in males and females for the prevention of genital warts caused by HPV types 6 and 11. The vaccine is approved for these uses in females and males ages 9 to 26. The FDA has also approved a cancer preventive vaccine that protects against hepatitis B virus (HBV) infection.

Inovio�� VGX-3100 is designed to raise immune responses against the E6 and E7 genes of HPV types 16 and 18 that are present in both pre-cancerous and cancerous cells transformed by these HPV types. E6 and E7 are oncogenes that play an integral role in transforming HPV-infected cells into cancerous cells. In March 2011, it initiated a randomized, double-blind Phase II study of VGX-3100 delivered using the CELLECTRA intramuscular electroporation device in women with HPV Type 16 or 18 and diagnosed with, but not yet treated for, cervical intraepithelial neoplasia (CIN) 2/3. The study is designed to enroll 148 subjects. In January 2011, it announced the publication of a scientific paper in the journal Human Vaccines detailing potent immune responses in a preclinical study of its SynCon vaccine for prostate cancer targeting two antigens, prostate specific antigen (PSA) and prostate specific membrane antigen (PSMA).

In January 2011, the Company announced the regulatory approval of a Phase II clinical trial (WIN Trial) to treat leukemia utilizing its new ELGEN 1000 automated vaccine delivery device. The single dose level, Phase II study, called WT1 immunity via DNA fusion gene vaccination in haematological malignancies by intramuscular injection followed by intramuscular electroporation. Cancer Vaccines encodes for hTERT, an antigen related to non-small cell lung, breast and prostate cancers. The vaccine is delivered using its electroporation delivery technology.

Infectious Disease Synthetic Vaccines

In Marc! h 2011, the Company announced the initiation of a follow-on open label, single dose Phase II clinical study in collaboration with ChronTech of the ChronVac-C HCV DNA vaccine delivered using its electroporation technology in treatment naive HCV infected individuals. Its HIV vaccines consist of candidates for HIV prevention, as well as therapy or treatment. PENNVAX-B is designed to target HIV clade B (most commonly found in the United States, North America, Australia and the European Union (EU). PENNVAX-G is designed to target HIV clades A, C and D, which are more commonly found in Asia, Africa, Russia and South America. This Phase I clinical study of PENNVAX-B (HVTN-080) vaccinated 48 healthy, HIV-negative volunteers to assess safety and levels of immune responses generated by Inovio�� PENNVAX-B vaccine delivered with its CELLECTRA electroporation device. PENNVAX-B is a SynCon vaccine that targets HIV gag, pol, and env proteins.

The Company�� VGX-3400X targets H5N1. The vaccine consists of three distinct DNA plasmids coded for a consensus hemagglutinin (HA) antigen derived from different H5N1 virus strains; a consensus neuraminidase (NA) antigen derived from different N1 sequences; and a consensus nucleoprotein (NP) fused to a small portion of the m2 protein (m2E) based on a broader cross-section of influenza viruses in addition to H5N1 and H1N1. Conventional vaccines are strain-specific and have limited ability to protect against genetic shifts in the influenza strains they target. They are therefore modified annually in anticipation of the next flu season�� new strain(s). It is focused on developing DNA-based influenza vaccines able to provide broad protection against known as well as newly emerging, unknown seasonal and pandemic influenza strains.

Animal Health/Veterinary

VGX Animal Health, Inc. (VGX AH), a majority-owned subsidiary, has licensed LifeTide, a plasmid-based growth hormone releasing hormone (GHRH) technology for swine. LifeTide is one of onl! y four DN! A-based treatments approved for use in animals and is the only DNA-based agent delivered using electroporation that has been granted marketing approval (Australia). VGX AH is also developing a GHRH-based treatment for cancer and anemia in dogs and cats. It is developing a synthetic vaccine for foot-and-mouth disease (FMD) administered by its vaccine delivery technology. The FMD virus is one of the most infectious diseases affecting farm animals, including cattle, swine, sheep and goats, and is a serious threat to global food safety.

The Company competes with Crucell N.V, Sanofi-Aventis, Novartis, Inc., GlaxoSmithKline plc, Merck, Pfizer, AstraZeneca, Inc., Novartis, Inc., MedImmune and CSL.

Advisors' Opinion:

• [By Sean Williams]

  No fairytale ending
  Fairytale endings work great in the movies, but you rarely see them come to fruition in the real world. Small-cap biopharmaceutical Inovio Pharmaceuticals (NYSEMKT: INO  ) has seen shares nearly triple since April on the heels of multiple intriguing studies, but will the glass slipper fit over the long term?

• [By Jake L'Ecuyer]

  Inovio Pharmaceuticals (NYSE: INO) was also up, gaining 10.53 percent to $3.57 after the company received the ��est Theraputic Vaccine��award at the World Vaccine Congress after the close Wednesday.

• [By George Budwell]

  Inovio Pharmaceuticals (NYSEMKT: INO  ) develops DNA-based vaccines and delivers them using a proprietary electroporation technique. Shares of Inovio have been a roller coaster all year long, and have certainly been the playground of day traders. Last week, Inovio shares lost more than 10% of their value on heavy volume, suggesting the stock may continue to experience downward pressure. This rapid move downward is surprising because the company recently signed a licensing deal with Roche (NASDAQOTH: RHHBY  ) to commercialize Inovio's multi-antigen DNA immunotherapies for prostate cancer and hepatitis B. As part of the deal, Inovio received $10 million upfront, and milestone payments could go as high as $412 million.

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of Inovio Pharmaceuticals (NYSE: INO) were down on Friday's session, falling 13.28 percent to $2.488 despite seemingly little news on the company.

Top 10 Tech Stocks To Watch For 2015: KVH Industries Inc.(KVHI)

KVH Industries, Inc. engages in the development, manufacture, and marketing of mobile communication products for the marine, land mobile, and aeronautical markets primarily in North America, Europe, and Asia. The company also offers navigation, guidance, and stabilization products for the defense and commercial markets. Its mobile communications products and airtime services include TracVision; TracPhone; CommBox system, a middleware software; and mini-VSAT broadband airtime, which enable customers to receive voice, Internet, and live digital television services in their marine vessels, recreational vehicles, automobiles, and commercial airplanes through satellite. The company?s guidance and stabilization products consist of precision fiber optic gyro based systems that help stabilize platforms, such as gun turrets, remote weapon stations, and radar units, as well as provides guidance for munitions; and tactical navigation systems that offer access to navigation and point ing information in a range of military vehicles, including tactical trucks and light armored vehicles. Its guidance and stabilization products are used in various commercial applications comprising precision mapping, dynamic surveying, autonomous vehicles, train location control and track geometry measurement systems, industrial robotics, and optical stabilization. The company sells its mobile communications products through an international network of retailers, distributors, and dealers; and guidance and stabilization products directly to the United States and allied governments, and government contractors, as well as through an international network of authorized independent sales representatives. It also leases its products directly to end users. The company was founded in 1978 and is headquartered in Middletown, Rhode Island.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  In trading on Thursday, technology shares were relative laggards, down on the day by about 0.08%. Top decliners in the sector included KVH Industries (NASDAQ: KVHI), off 8.6%, and Yandex NV (NASDAQ: YNDX), down 7.3%.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on KVH Industries (Nasdaq: KVHI  ) , whose recent revenue and earnings are plotted below.

Top 10 Tech Stocks To Watch For 2015: GigaMedia Limited (GIGM)

Gigamedia Limited, through its subsidiaries, primarily engages in the operation of online games for online game players in Asia. The company provides a portfolio of online games, including MahJong, a traditional Chinese tile game; MMORPG, an Internet-based computer game; advanced casual games; and card, chance-based, and simple casual games. It also develops and licenses online poker, casino, and sports betting gaming software solutions, as well as offers application services for the online poker and casino markets primarily in the continental European markets. The company has strategic alliances with SoftStar Entertainment Inc., Neostorm Holdings Limited, XLGames Inc., Access China Holding Limited, Gorilla Banana Entertainment Corp., JC Entertainment Corporation, Possibility Space Incorporated, East Gate Media Contents & Technology Fund, and BetClic. GigaMedia Limited was founded in 1997 and is headquartered in Taipei, Taiwan.

Advisors' Opinion:

• [By Eric Volkman]

  GigaMedia (NASDAQ: GIGM  ) results for the company's fiscal Q4 and 2012 have been released. For the quarter, revenue was $4.8 million, down by 34% from the $7.4 million in the same period the previous year. Attributable net loss, however, narrowed considerably to $15.4 million ($0.30 per diluted share) from Q4 2011's shortfall of $51.3 million ($1.01).

Top 10 Tech Stocks To Watch For 2015: Stemline Therapeutics Inc (STML)

Stemline Therapeutics, Inc. (Stemline), incorporated on August 8, 2003, is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target both cancer stem cells (CSCs) and tumor bulk. The Company is developing two clinical-stage product candidates, SL-401 and SL-701, for which it holds global marketing rights. The indication for SL-401, a biologic-drug conjugate, is acute myeloid leukemia (AML). The indications for SL-701, a synthetic peptide vaccine, are pediatric and adult brain cancer. It has a platform, StemScreen, for the discovery of CSC-targeted compounds, from which it has discovered or validated several of its clinical and preclinical product candidates. Stemline�� StemScreen consists of StemScreen-1 and StemScreen-2 for the identification of CSC-directed compounds.

SL-301 is a small molecule gamma-secretase inhibitor that inhibits Notch, a pathway expressed by CSCs and tumor bulk of multiple cancer types. SL-101 is a monoclonal antibody-based (mAb -based) compound that targets CD123 and has shown in vitro activity against certain hematologic cancers. SL-201 is a small molecule active against certain hematologic and solid tumor types. SL-601 is a mAb-based compound that targets a cell surface marker on bladder CSCs, which is also expressed on a variety of other solid tumor types. It has also in-licensed certain intellectual property directed to mAb-based therapeutics to validated oncology targets, including Glypican-3, Tie-1, CD133, Frizzled, Smoothened and Patched.

SL-401 - An IL-3R-Directed Compound Targeting Cancer Stem Cells and Tumor Bulk

SL-401 is a clinically active biologic-drug conjugate consisting of human interleukin-3 (IL-3) genetically linked to a truncated version of diphtheria toxin. SL-401 targets the IL-3 receptor (IL-3R), which is overexpressed on both the CSCs and tumor bulk of multiple hematologic cancers, including AML. SL-401 has demonstrated preclinical in vit! ro and in vivo activity against both leukemia blasts (which includes tumor bulk) and CSCs of a range of human leukemia cell lines and primary leukemia cells from patients.

SL-701

SL-701 is a clinically active synthetic peptide vaccine that targets several epitopes on CSCs and tumor bulk of brain cancer. In two completed Phase 1/2 clinical trials, SL-701 demonstrated single agent anti-tumor activity in pediatric patients with newly diagnosed brainstem glioma (BSG) and other high-grade gliomas (HGGs) and in adult patients with refractory or recurrent GBM, and other HGGs.

StemScreen-1

StemScreen-1 is a drug discovery platform designed to identify CSC-targeted compounds based on the isolation of CSCs and evaluation of CSC gene expression profiles. CSCs are isolated from primary tumor tissue or cell lines, and then subjected to gene expression analysis using a variety of technologies, including microarray. A control tissue, such as normal bone marrow is analyzed as a comparator against the gene expression profile of the isolated CSCs. These data are then interfaced with an information base of compounds and their mechanisms of action (that is which gene products and pathways they impact). It has utilized StemScreen-1 to discover a number of its preclinical drug candidates. These include SL-201, SL-301, and SL-601. In addition, SL-401 demonstrated activity against CSCs as determined by both an in vitro colony formation and in vivo animal implantation assay, thereby validating certain StemScreen-1 anti-CSC assays.

StemScreen-2

StemScreen-2 is a high throughput drug discovery platform it is developing to discover anti-CSC compounds. StemScreen-2 utilizes a cell-based assay that can track and follow CSCs in their natural state during high throughput screening. In particular, StemScreen-2 utilizes a CSC-specific promoter linked to a reporter as a method for identifying and following CSCs in their native environment of surrounding tumor b! ulk. In t! his way, StemScreen-2 enables the identification of compound hits, in a high throughput manner, with anti-CSC activity.

The Company competes with Boston Biomedical, Inc., Eclipse Therapeutics, Inc., OncoMed Pharmaceuticals, Inc., Verastem, Inc., Astellas Pharma US, Inc., Boehringer Ingelheim GmbH, Dainippon Sumitomo Pharma Co. Ltd., Geron Corp., GlaxoSmithKline plc, ImmunoCellular Therapeutics, Ltd, Macrogenics Inc., Amgen, Inc., Pfizer Inc., Roche Holding AG, Sanofi U.S. LLC., Cyclacel Pharmaceuticals, Inc., Sunesis Pharmaceuticals Inc., Clavis Pharma ASA, Ambit Biosciences Corporation, Celgene Corporation, Eisai Co. Ltd., Celator Pharmaceuticals, Inc., Merck & Co., Inc., Eisai Co., Inc., Roche Holding AG, Novartis AG and Celldex Therapeutics, Inc.

Advisors' Opinion:

• [By Jay Silverman]

  Some of the biggest leaders in that field, and there have been dozens in fields, if not more this year, such as Bluebird (BLUE) and Stemline Therapeutics (STML) and have all pulled back to significantly lower levels; even below, in Bluebird's case, the price that had actually opened up as an IPO, even though it's above its IPO price.

• [By David Zeiler]

  3. Stemline Therapeutics Inc. (Nasdaq: STML): This biotech develops drugs that target cancer stem cells and tumors. Stemline went public January 29 at $10 a share and rose just 11.78% on its first day. But STML has climbed steadily since, and currently trades at $37.46, up 274.6% from its IPO price.

• [By Keith Speights]

  Best-performing biotech IPO
  Stemline Therapeutics� (NASDAQ: STML  ) has only traded publicly this year, but what a year it's been. The stock's performance ranks Stemline as the best-performing biotech IPO so far in 2013. This week has been pretty good also, with shares moving up by 28%.

Top 10 Tech Stocks To Watch For 2015: SilverSun Technologies Inc (SSNT)

SilverSun Technologies Inc, formerly Trey Resources, Inc., incorporated on October 3, 2002, is a business consultant for small and medium sized businesses and resellers and developers of financial accounting software. It also publishes its own electronic data interchange (EDI) software. It specializes in software integration and deployment, programming, and training and technical support, aimed at improving the financial reporting and operational efficiencies of small and medium sized companies. The sale of its financial accounting software is concentrated in the northeastern United States, while its EDI software and programming services are sold to corporations nationwide. It also provides software customization, data migration, business consulting, and implementation assistance for complex design environments. The Company�� three product categories include Financial Accounting Software, Electronic Data Interchange (EDI) Software and Warehouse Management Systems. Its services include network services and business consulting. In January 2012, the Company acquired the Sage software customer accounts of IncorTech. In January 2012, the Company acquired remaining 20% of SWK Technologies. In April 2012, its subsidiary, SWK Technologies, sold the Sage ERP X3 global enterprise solution to a power generation facility in the Northeastern United States. In June 2012, the Company acquired Micro-Point, Inc. In February 2013, the Company's SWK Technologies, Inc. acquired Sage business partner accounts of Point Solutions, LLC. In February 2013, its wholly owned subsidiary, SWK Technologies Inc., completed the acquisition of the Sage business partner accounts of Colleyville, Texas-based SGEN, LLC (d/b/a Software Generation).

Financial Accounting Software

The Company resells accounting software published by Sage Software, Inc. (Sage) and Intuit, Inc. for the financial accounting requirements of small and medium sized businesses focused on manufacturing and distribution, and the delivery of! related services from the sales of these products, including installation, support and training. These product sales are primarily packaged software programs installed on a user workstation, on a local area network server, or in a hosted environment. The programs perform and support a variety of functions related to accounting, including financial reporting, accounts payable and accounts receivable, and inventory management. The Company provides a variety of services along with its financial accounting software sales. These services include training, technical support, and professional services. It also provides on-site training services that are tailored to meet the needs of a particular customer. It provides end-user technical support services through our support/help desk. Its professional services include project-focused offerings, such as software customization, data migration, and small and medium sized business consulting.

The Company competes with Microsoft.

Electronic Data Interchange (EDI) Software

The Company publishes its own EDI software MAPADOC. The MAPADOC EDI solution is a fully integrated EDI solution that provides users of Sage Software�� MAS family of accounting software products. MAPADOC provides the user with data entry time, elimination of redundant steps, the lowering of paper and postage costs, the reduction of time spent typing, signing, checking and approving documents and the ability to self-manage EDI. The Company markets MAPADOC solutions to its existing and new small and medium-sized business customers, and through a network of resellers.

The Company competes with True Commerce and Kissinger Associates.

Warehouse Management System (WMS)

The Company is a reseller of the Warehouse Management System (WMS) software published by Accellos, Inc. Accellos, Inc. develops warehouse management software for mid-market distributors. The primary purpose of a WMS is to control the movement and storage of mat! erials wi! thin an operation and process the associated transactions. The detailed setup and processing within a WMS can vary from one software vendor to another. The basic WMS uses a combination of item, location, quantity, unit of measure, and order information to determine where to stock, where to pick, and in what sequence to perform these operations. Accellos works as part of a operational solution by integrating seamlessly with RF hardware, accounting software, shipping systems and warehouse automation equipment. The Company markets the Accellos solution to its existing and new medium-sized business customers.

Network Services And Business Consulting

The Company provides network maintenance and service upgrades for its business clients. It provides various services for its clients, including server implementation, support and assistance, operation and maintenance of central systems, technical design of network infrastructure, technical troubleshooting for large scale problems, network and server security, and backup, archiving, and storage of data from servers.

Advisors' Opinion:

• [By CRWE]

  Today, SSNT has shed (-8.33%) down -0.010 at $.110 with 3,500 shares in play thus far (ref. google finance Delayed: 10:08AM EDT September 12, 2013).

  SilverSun Technologies, Inc. previously reported its second quarter results for the three and six months ended June 30, 2013.

  Financial highlights for 3 months ended June 30, 2013 compared to 3 months ended june 30, 2012 are as follows. The Company reported revenues increased to $3,870,598, rising 26% from $3,071,425. Software sales climbed 14% to $528,368 from $462,151. Services revenues totaled $3,342,230, increasing 28% from $2,609,264. Income from operations rose to $77,339 from a loss from operations of $319,781. Net income was $62,185, or $0.00 earnings per basic and diluted share, compared to a net loss of $334,031, or 0.00 loss per basic and diluted share.

Top 10 Tech Stocks To Watch For 2015: QUALCOMM Incorporated(QCOM)

QUALCOMM Incorporated engages in the development, design, manufacture, and marketing of digital wireless telecommunications products and services. The company operates in four segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), Qualcomm Wireless and Internet (QWI), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies code division multiple access (CDMA)-based integrated circuits and system software for wireless voice and data communications, multimedia functions and global positioning system products. The QTL segment grants licenses to use portions of its intellectual property portfolio comprising patent rights useful in the manufacture and sale of wireless products, such as products implementing cdmaOne, CDMA2000, WCDMA, CDMA TDD, GSM/GPRS/EDGE, and/or OFDMA standards and their derivatives The QWI segment consists of Qualcomm Internet Services that provides content enablement services for the wireless industry and pu sh-to-talk and other products and services for wireless network operators; Qualcomm Government Technologies, which offers development, hardware, and analytical services to the United States government agencies involving wireless communications technologies; Qualcomm Enterprise Services that provides satellite and terrestrial-based two-way data messaging, position reporting, wireless application services, and managed data services to transportation and logistics companies and other enterprise companies; and Firethorn, which builds and manages software applications that enable mobile commerce services. The QSI segment makes strategic investments to support the worldwide adoption of CDMA- and OFDMA-based technologies and services. QUALCOMM Incorporated primarily operates in China, South Korea, Taiwan, Japan, and the United States. The company was founded in 1985 and is based in San Diego, California.

Advisors' Opinion:

• [By Paul Ausick]

  Stocks on the Move: ParkerVision Inc. (NASDAQ: PRKR) is down 59.2% at $2.89 following a smaller-than-hoped-for award in its patent suit against Qualcomm Inc. (NASDAQ: QCOM). NQ Mobile Inc. (NYSE: NQ) is down 50.7% at $11.28 following a blistering from analysts at Muddy Waters.

Top 10 Tech Stocks To Watch For 2015: SciQuest Inc.(SQI)

SciQuest, Inc. provides an on-demand strategic procurement and supplier enablement solution worldwide. The company?s solution integrates its customers with their suppliers for automating the source-to-settle process. Its solution include various modules, such as sourcing director, spend director, requisition manager, order manager, settlement manager, supplier contract management and authoring, total supplier manager, supplier diversity manager, and materials management. The company delivers its solutions over the Internet using a software-as-a-service model. It serves higher education, life sciences, healthcare, state and local government entities, and commercial customers through direct sales force. SciQuest, Inc. was founded in 1995 and is headquartered in Cary, North Carolina.

Advisors' Opinion:

• [By Holly LaFon]

  A second company that makes enterprise software is SciQuest (SQI), which provides procurements and spending management software on a subscription basis. Unlike one of its chief competitors, which targets everyday supply purchases made by big companies, SciQuest provides automated purchasing to a different segment by focusing on universities, hospitals, local and state governments, etc.